Evidence map›Paper›PMID 20360033›Full record

ArticleMolecular & cellular proteomics : MCP2011

Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni.

Nichollas E Scott, Benjamin L Parker, Angela M Connolly, Jana Paulech, Alistair V G Edwards, Ben Crossett, Linda Falconer, Daniel Kolarich, Steven P Djordjevic, Peter Højrup and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 1 synthesis or guideline pooled it, 341 citations in OpenAlex.

  1. Pooled it
  2. Rare missense variants inFrontiers in genetics · 2026
    Article
  3. Article
  4. Review
  5. Molecular model of a bacterial flagellar motorbioRxiv : the preprint server for biology · 2024
    Article
  6. Journal of bacteriology · 2024
    Article
  7. Glycoproteomic and proteomic analysis ofMicrobiology spectrum · 2024
    Article
  8. Article
  9. Article
  10. Can We BoostJournal of the American Society for Mass Spectrometry · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. CRISPRi-Mediated Silencing ofJournal of proteome research · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Oxidative desulfurization pathway for complete catabolism of sulfoquinovose by bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Nichollas E ScottSchool of Molecular and Microbial Biosciences, University of Sydney, Sydney, Australia.
Benjamin L Parker
Angela M Connolly
Jana Paulech
Alistair V G Edwards
Ben Crossett
Linda Falconer
Daniel Kolarich
Steven P Djordjevic
Peter Højrup
Nicolle H Packer
Martin R Larsen
Stuart J Cordwell
University of Southern Denmark · DKUniversity of Sydney · AUUniversity of Technology Sydney · AUNew South Wales Department of Primary Industries · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Campylobacter jejuni is a gastrointestinal pathogen that is able to modify membrane and periplasmic proteins by the N-linked addition of a 7-residue glycan at the strict attachment motif (D/E)XNX(S/T). Strategies for a comprehensive analysis of the targets of glycosylation, however, are hampered by the resistance of the glycan-peptide bond to enzymatic digestion or β-elimination and have previously concentrated on soluble glycoproteins compatible with lectin affinity and gel-based approaches. We developed strategies for enriching C. jejuni HB93-13 glycopeptides using zwitterionic hydrophilic interaction chromatography and examined novel fragmentation, including collision-induced dissociation (CID) and higher energy collisional (C-trap) dissociation (HCD) as well as CID/electron transfer dissociation (ETD) mass spectrometry. CID/HCD enabled the identification of glycan structure and peptide backbone, allowing glycopeptide identification, whereas CID/ETD enabled the elucidation of glycosylation sites by maintaining the glycan-peptide linkage. A total of 130 glycopeptides, representing 75 glycosylation sites, were identified from LC-MS/MS using zwitterionic hydrophilic interaction chromatography coupled to CID/HCD and CID/ETD. CID/HCD provided the majority of the identifications (73 sites) compared with ETD (26 sites). We also examined soluble glycoproteins by soybean agglutinin affinity and two-dimensional electrophoresis and identified a further six glycosylation sites. This study more than doubles the number of confirmed N-linked glycosylation sites in C. jejuni and is the first to utilize HCD fragmentation for glycopeptide identification with intact glycan. We also show that hydrophobic integral membrane proteins are significant targets of glycosylation in this organism. Our data demonstrate that peptide-centric approaches coupled to novel mass spectrometric fragmentation techniques may be suitable for application to eukaryotic glycoproteins for simultaneous elucidation of glycan structures and peptide sequence.

Indexed as

Campylobacter jejuniCell MembraneChromatographyElectronsElectron TransportElectrophoresis, Gel, Two-DimensionalGenomeGlycine maxGlycopeptidesGlycosylationHydrophobic and Hydrophilic InteractionsMass SpectrometryPeptidesPolysaccharidesProtein Structure, TertiaryGlycopeptidesPeptidesPolysaccharides

Identifiers

PMID20360033
PMCPMC3033663
OpenAlexW2010927211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.